GovChime
AWARDDELIVERY ORDEROther than small business

Delivery order 75F40122F19002DENVER HEALTH AND HOSPITAL AUTHORITY

Overview

Award facts

Net obligations
$518.71K
$518,714of $630.21K potential value
Outlays (paid to date)
$386.58K
$386.58K paid of $518.71K obligated$386,580
Period of performance
Aug 31, 2022 to Sep 28, 2027
Ends in 10 months
Modifications
6
Latest action Jun 24, 2026
Contract type
Delivery order
PIID 75F40122F19002

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

UNDERSTANDING THE PREVALENCE, EXPERIENCES, KNOWLEDGE, AND PERCEPTIONS OF FALSIFIED AND UNAPPROVED PHARMACEUTICALS IN A GENERAL POPULATION RECRUITED THROUGH AN ONLINE PANEL SURVEY

Dates and value

Award date
Signed on Aug 31, 2022
Current value
$518,714Base and exercised options
Potential value (if all options are exercised)
$630,211
Parent contract vehicle
75F40121D00033 (IDC, multiple award) — 6 orders recorded under it

Obligations by fiscal year of action

  • FY2026: $108,250
  • FY2025: $105,097
  • FY2024: $102,036
  • FY2022: $203,331

Total across 4 fiscal years: $518,714

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jun 24, 2026. View on USAspending · Recipient on SAM.gov

Recipient

NameDENVER HEALTH AND HOSPITAL AUTHORITY
LocationDENVER, CO
UEIMMT4LGM4H9Z5
CAGE code1RS53
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeUS government entity
Parent companyDENVER HEALTH AND HOSPITAL AUTHORITY

Business types and certifications

U.S. government entity

Self-reported at the time of the action.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded from
Human drugs; Fda user fees (non general fund)Program activities075-0600Federal accounts (agency financial reports)

Place of performance

Place of performance
Silver Spring, Montgomery County, Maryland 20993-0001
Congressional district (place of performance)
MD-08As reported at the time of the action

Classification and competition

Classification

NAICS
541715RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
Product or service (PSC)
B529SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA (service)

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Subject to multiple award fair opportunityMAFO
Set-aside
Not reported
Contract pricing
Firm fixed priceJ
Offers received
1

Contract details

Subcontracting plan
Plan not requiredB
Certified cost or pricing data
Not obtained - waivedW
Commercial procedures
Commercial products/servicesA
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Transaction history

Modification history

Base award
Aug 31, 2022Base obligation at award: $203,331
Latest action
Jun 24, 2026 — Other administrative actionModification P00006; administrative: no change in scope or value
Latest substantive action
Mar 17, 2026 — Option exercisedModification P00005; obligation change +$108,250
Actions by type
  • Base award1
  • Option exercised3
  • Other administrative action3
7 actions recorded, Aug 31, 2022 to Jun 24, 2026; each action counted once.

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Inherently governmental functions
Closely associatedCL
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
Other U.S. entity (e.g. government)B
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Delivery orderC
Parent vehicle type
IDCB
Parent vehicle: multiple or single award
Multiple awardM
Parent vehicle agency
Food And Drug Administration7524
Awarding agency code
7500
Awarding sub-tier code
7524
Contracting office code
75F401
Transactions recorded under this award key
7

Funding

Funding agency code
7500
Funding sub-tier code
7524
Funding office code
75F401
Treasury accounts
  • 075-2022/2022-0600-000
  • 075-X-0600-000
Object classes
  • 25.2: Other services from non-Federal sources
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression